Cited by 19CRISPR and Genetic EngineeringRNA regulation and diseaseMachine Learning in Bioinformatics

A systematic evaluation of data processing and problem formulation of CRISPR off-target site prediction

Open access
Yaish, Ofir, Asif, Maor, Orenstein, Yaron·2022·Briefings in Bioinformatics

Published version of a preprint

Abstract

CRISPR/Cas9 system is widely used in a broad range of gene-editing applications. While this editing technique is quite accurate in the target region, there may be many unplanned off-target sites (OTSs). Consequently, a plethora of computational methods have been developed to predict off-target cleavage sites given a guide RNA and a reference genome. However, these methods are based on small-scale datasets (only tens to hundreds of OTSs) produced by experimental techniques to detect OTSs with a low signal-to-noise ratio. Recently, CHANGE-seq, a new in vitro experimental technique to detect OTSs, was used to produce a dataset of unprecedented scale and quality (>200 000 OTS over 110 guide RNAs). In addition, the same study included in cellula GUIDE-seq experiments for 58 of the guide RNAs. Here, we fill the gap in previous computational methods by utilizing these data to systematically evaluate data processing and formulation of the CRISPR OTSs prediction problem. Our evaluations show that data transformation as a pre-processing phase is critical prior to model training. Moreover, we demonstrate the improvement gained by adding potential inactive OTSs to the training datasets. Furthermore, our results point to the importance of adding the number of mismatches between guide RNAs and their OTSs as a feature. Finally, we present predictive off-target in cellula models based on both in vitro and in cellula data and compare them to state-of-the-art methods in predicting true OTSs. Our conclusions will be instrumental in any future development of an off-target predictor based on high-throughput datasets.

Integrity signals

Registry

Crossref · 10.1093/bib/bbac157

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • LNP delivery in vivo can be quickly degraded.

    “| Delivery methods improvement | Application in vivo [95–105] | LNP: Can be quickly degraded in vivo | Eliminate off-target effects |”

    From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as [97]

  • AAV delivery in vivo lasts for years in terminally differentiated cell types.

    “| Delivery methods improvement | Application in vivo [95–105] | AAV: Last for years in terminally differentiated cell types | May cause accumulation of off-target mutations |”

    From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as [97]

  • LNP delivery in vivo eliminates off-target effects.

    “| Delivery methods improvement | Application in vivo [95–105] | LNP: Can be quickly degraded in vivo | Eliminate off-target effects |”

    From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as [97]

  • AAV delivery in vivo may cause accumulation of off-target mutations.

    “| Delivery methods improvement | Application in vivo [95–105] | AAV: Last for years in terminally differentiated cell types | May cause accumulation of off-target mutations |”

    From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as [97]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Yaish, O., Asif, M., & Orenstein, Y.
Affiliations
Ben-Gurion University of the Negev (IL)
Corresponding author
Orenstein, Yaron
Venue
Briefings in Bioinformatics
Published
2022-05-20
Volume
23
Issue
5
ISSN
  • 1467-5463 (ISSN-L)
  • 1477-4054
OpenAlex
W4226215757
Cited by
19
References
51
Citations by year
2026: 3 · 2025: 6 · 2024: 7 · 2023: 3
FWCI
1.31
Type
journal article
Language
en
Open access
Locations
  • Briefings in Bioinformatics (publishedVersion)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nd)
  • PubMed (publishedVersion)
Funders
  • Israel Innovation Authority through the CRISPR-IL Consortium
  • Israel Science Foundation (351/22)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Machine Learning in Bioinformatics
Keywords
CRISPR/Cas9, guide RNA, GUIDE-seq, data preprocessing, high-throughput sequencing data, genome editing
MeSH terms
Gene Editing, RNA, Guide, CRISPR-Cas Systems, Research Design, CRISPR-Cas Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review